부산대학교 도서관

The aim of the second edition of our Special Issue, entitled I "Nonalcoholic Fatty Liver Disease/Metabolic Associated Fatty Liver Disease: New Insights 2.0" i , is to report the recent experimental and observational studies about NAFLD/MAFLD, which is the most common chronic liver disease worldwide to date [[1]]. Therefore, maybe, the use of more techniques to identify (non-invasively) patients with NAFLD/MAFLD and liver fibrosis might be more appropriate in clinical practice. 36555127 20 Mantovani A., Lombardi R., Cattazzo F., Zusi C., Cappelli D., Dalbeni A. MAFLD and CKD: An Updated Narrative Review. Among original articles, Mantovani et al. showed that the presence of Fibroscan SP ® sp -assessed significant fibrosis was independently associated with an increased risk of developing worse glycaemic control in female patients with type 2 diabetes (T2DM) and NAFLD/MAFLD [[2]]. [Extracted from the article]